CN102219798A - Method for preparing diisopinocampheylborane and methoxydiisopinocampheylborane - Google Patents

Method for preparing diisopinocampheylborane and methoxydiisopinocampheylborane Download PDF

Info

Publication number
CN102219798A
CN102219798A CN2010101457745A CN201010145774A CN102219798A CN 102219798 A CN102219798 A CN 102219798A CN 2010101457745 A CN2010101457745 A CN 2010101457745A CN 201010145774 A CN201010145774 A CN 201010145774A CN 102219798 A CN102219798 A CN 102219798A
Authority
CN
China
Prior art keywords
cas
borine
preparation
borines
methoxyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2010101457745A
Other languages
Chinese (zh)
Other versions
CN102219798B (en
Inventor
冯虎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI SCIENTIA PHARMACEUTICAL TECHNOLOGY CO LTD
Original Assignee
SHANGHAI SCIENTIA PHARMACEUTICAL TECHNOLOGY CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI SCIENTIA PHARMACEUTICAL TECHNOLOGY CO LTD filed Critical SHANGHAI SCIENTIA PHARMACEUTICAL TECHNOLOGY CO LTD
Priority to CN201010145774.5A priority Critical patent/CN102219798B/en
Publication of CN102219798A publication Critical patent/CN102219798A/en
Application granted granted Critical
Publication of CN102219798B publication Critical patent/CN102219798B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention provides a method for preparing diisopinocampheylborane and methoxydiisopinocampheylborane, which comprises the following steps of: dripping (+)-alpha-pinene or (-)-alpha-pinene into borane tetrahydrofuran solution slowly, and adding glycol dimethyl ether into precipitated white solids for multiple times to obtain (-)-diisopinocampheylborane or (+)-diisopinocampheylborane; and reacting the (+)-diisopinocampheylborane and the (-)-diisopinocampheylborane with absolute methanol respectively to prepare (+)-B-methoxydiisopinocampheylborane and (-)-B-methoxydiisopinocampheylborane. The method is simple and convenient, stable and reliable, low in cost, high in purity and high in production rate.

Description

The preparation method of diisopinocampheylchloroborane thiazolinyl borine and methoxyl group two different loose camphyl borines
Technical field
The invention belongs to technical field of pharmaceutical chemistry, especially the preparation method of methoxyl group two different loose camphyl borines and diisopinocampheylchloroborane thiazolinyl borine.
Technical background
The medicine chirality is the important topic of new drug design, discovery, exploitation, listing and sale.Stereochemistry is pharmacological basic sides.The progress of three-dimensional selection bioanalysis causes solid is selected the new knowledge of pharmacodynamics and pharmacokinetics, makes and can distinguish enantiomorph to overall pharmaceutically-active Relative Contribution.When a kind of enantiomorph was undertaken certain interested pharmaceutical activity, its pairing enantiomorph may be non-activity or have some interesting activity, was a kind of antagonist of active enantiomorph or had possibility and need or unwanted not same-action.Consider these possibilities, use the pure medicine of stereochemistry as if to have more advantage, for example reduce total dosage, expansion treatment window, reduce variability and more accurate estimation dosage-response relation between individuality.These factors cause industry and code administration department to pay attention to single enantiomer more.U.S. FDA had at first formally been announced the chiral drug code administration guide that is entitled as " new stereoisomerism drug development statement of the policy " in 1992, and European Union has also announced the file of " chiral material research " in 1994 subsequently.According to estimates, the sales volume sustainable growth of world's single enantiomer form chiral drug.The market share of single enantiomer shape pharmaceutical preparation is increased to about 39% (1,519 hundred million dollars) in 2002 from 27% (74,400,000,000 dollars) in 1996.Anti-hepatitis b new drug Entecavir is the efabirenz in the antiviral, and this medicine can destroy duplicating of hepatitis B virus and quantity.Produce by Bristol Myers Squibb group, ratified and the medicine of the conduct control hepatitis B state of an illness through FDA Food and Drug Administration in 2005.Its most critical intermediate (1R, 2S)-2-(benzyloxymethyl)-3-cyclopentenes-1-is pure to be prepared from by diisopinocampheylchloroborane thiazolinyl borine in the patent of the present invention exactly.
The present invention mainly is the main raw material at reduction reaction in the chiral drug, is reduced to alcohol, two key and triple-linked reduction etc. as ketone.Methoxyl group two different loose camphyl borines and diisopinocampheylchloroborane thiazolinyl borine all are the strong and difficult chiral reduction reagent for preparing of reducing power, and the specific product title is respectively (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5), (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7), (+)-B-methoxyl group two different loose camphyl borines (CAS:99438-28-5) and (-)-B-methoxyl group two different loose camphyl borines (CAS:85134-98-1).They are the key intermediates in the chiral drug preparation process such as Entecavir, and these pharmaceutical intermediates mainly by import, cost an arm and a leg.The yet own preparation of the domestic company that has at present, but their employed raw material: 1, α-Pai Xi does not reach requirement owing to homemade, needs import yet; 2, the borine tetrahydrofuran solution also is import, and price is very high.If 3 borine dimethyl sulphides with import, price height not only, smell also is very unpleasant.
Summary of the invention
The objective of the invention is to overcome the deficiency of prior art, it is homemade, as the to have overcome imported raw material high shortcoming of cost that the preparation method of the diisopinocampheylchloroborane thiazolinyl borine that a kind of technology is simple, with low cost, purity is high, whole raw material are provided.
Another purpose of the present invention is to provide a kind of preparation method of methoxyl group two different loose camphyl borines.
The preparation method of diisopinocampheylchloroborane thiazolinyl borine of the present invention comprises following step:
(1) the borine tetrahydrofuran solution is cooled to-20 ℃~10 ℃ with the cryosel bath, to wherein slowly dripping (+)-α-Pai Xi (CAS:7785-70-8) or (-)-α-Pai Xi (CAS:7785-26-4), keeps temperature under the nitrogen protection less than 0 ℃; After being added dropwise to complete, under 0 ℃ of temperature, left standstill 10~24 hours, have a large amount of white solids to separate out;
(2) supernatant liquid is shifted, stay layer solid and, solid is heated to 40 ℃~80 ℃ together, allow it slowly cool to room temperature then to wherein adding glycol dimethyl ether; With the ice bath cooling, left standstill 10~24 hours then, have a large amount of white solids to separate out;
(3) repeating step (2) operating process is 2~3 times;
(4) in step (1), drip (+)-α-Pai Xi (CAS:7785-70-8) and make (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7); In step (1), drip (-)-α-Pai Xi (CAS:7785-26-4) and make (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5).
Described borine Preparation of lithium triethylborohydride method, it comprises the steps:
(1) under the condition of nitrogen protection, will put into there-necked flask with the tetrahydrofuran (THF) that the sodium silk was handled, to wherein adding sodium borohydride, be cooled to-25 ℃~-15 ℃; Then to wherein slowly dripping boron trifluoride ether solution; In the dropping process, keep temperature-25 ℃~-15 ℃;
(2) be added dropwise to complete after, allow temperature slowly rise to room temperature, leave standstill and separated out a large amount of solids in 10~24 hours, obtaining upper strata water white transparency liquid is exactly the borine tetrahydrofuran solution;
Wherein, the used composition of raw materials ratio of above-mentioned processing step is: tetrahydrofuran (THF) 3~4L, sodium borohydride 0.08~0.12kg, boron trifluoride ether solution 0.4~0.5L.
The preparation method of methoxyl group two different loose camphyl borines of the present invention comprises (+)-preparation of B-methoxyl group two different loose camphyl borines (CAS:99438-28-5) and (-) B-methoxyl group two different loose camphyl borines (CAS:85134-98-1).
(+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) that above-mentioned steps is made makes (+) B-methoxyl group two different loose camphyl borines (CAS:99438-28-5) with the anhydrous methanol reaction.
Concrete grammar comprises the steps:
(1) (+) that above-mentioned steps is made-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) nitrogen protection is dry down, after the accurate weighing, nitrogen protection is transferred in the there-necked flask in glove box, add anhydrous methanol to there-necked flask, under-20~0 ℃ of temperature, react;
(2) after reaction was finished, solvent evaporated with anhydrous n-hexane washing 2 times, obtained (+)-B-methoxyl group two different loose camphyl borines (CAS:99438-28-5).
(-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) that above-mentioned steps is made makes (-)-B-methoxyl group two different loose camphyl borines (CAS:85134-98-1) with the anhydrous methanol reaction.
Concrete grammar comprises the steps:
(1) (-) that above-mentioned steps is made-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) nitrogen protection is dry down, after the accurate weighing, nitrogen protection is transferred in the there-necked flask in glove box, add anhydrous methanol to there-necked flask, under-20~0 ℃ of temperature, react;
(2) after reaction was finished, solvent evaporated with anhydrous n-hexane washing 2 times, obtained (-)-B-methoxyl group two different loose camphyl borines (CAS:85134-98-1).
The present invention has following advantage: the inventive method is easy, process stabilizing is reliable, and is with low cost, purity height, productivity height.In the present invention, we use homemade firpene (ee value 55%~70%); To also have other raw materials all be homemade, overcome with high costs that imported raw material brings, and it is low also to have overcome product purity, the unsettled shortcoming of quality.Certainly, need to prove, in this patent,, use our production method, can reach the effect among the embodiment equally if use imported raw material.
Embodiment
The present invention is further described below in conjunction with specific embodiment.
Embodiment 1 borine Preparation of lithium triethylborohydride:
(1) tetrahydrofuran (THF) that 3.5L was handled is put into the 10L there-necked flask, to wherein adding the 100g sodium borohydride, is cooled to-25 ℃; To wherein slowly dripping the 400ml boron trifluoride ether solution, more than react nitrogen protection then, in the dropping process, keep temperature less than-15 ℃.
(2) be added dropwise to complete after, allow temperature slowly rise to room temperature, leave standstill 12 hours bottoms and have a large amount of solids and separate out, careful and lentamente the upper strata colourless transparent liquid is transferred in the 10L there-necked flask, make the borine tetrahydrofuran solution; Nitrogen protection is with standby.
Embodiment 2 borine Preparation of lithium triethylborohydride:
(1) tetrahydrofuran (THF) that 3.5L was handled is put into the 10L there-necked flask, and to wherein adding the 100g sodium borohydride, ice bath is cooled to-25 ℃; To wherein slowly dripping the 450ml boron trifluoride ether solution, more than react nitrogen protection then, in the dropping process, keep temperature less than-15 ℃.
(2) be added dropwise to complete after, allow temperature slowly rise to room temperature, leave standstill 12 hours bottoms and have a large amount of solids and separate out, careful and lentamente the upper strata colourless transparent liquid is transferred in the 10L there-necked flask, make the borine tetrahydrofuran solution; Nitrogen protection is with standby.
Embodiment 3 (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) preparation:
(1) the borine tetrahydrofuran solution that embodiment 1 is made is bathed with cryosel and is cooled to-20 ℃~10 ℃, is homemade (-)-α-Pai Xi (CAS:7785-26-4) of 55% to wherein slowly dripping ee value under the nitrogen protection, and the maintenance temperature is less than 0 ℃; After being added dropwise to complete, under 0 ℃ of temperature, left standstill 12 hours, have a large amount of white solids to separate out;
(2) supernatant liquid is shifted, stay layer solid and, solid is heated to 50 ℃ together, allow it slowly cool to room temperature then to wherein adding glycol dimethyl ether; With the ice bath cooling, left standstill 12 hours then, have a large amount of white solids to separate out;
(3) repeating step (2) operating process is 3 times;
(4) obtain (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) (ee 99.15%) of high purity and optical purity at last.
Embodiment 4 (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) preparation:
(1) the borine tetrahydrofuran solution that embodiment 1 is made is bathed with cryosel and is cooled to-20 ℃~10 ℃, is homemade (-)-α-Pai Xi (CAS:7785-26-4) of 70% to wherein slowly dripping ee value under the nitrogen protection, and the maintenance temperature is less than 0 ℃; After being added dropwise to complete, under 0 ℃ of temperature, left standstill 12 hours, have a large amount of white solids to separate out;
(2) supernatant liquid is shifted, stay layer solid and, solid is heated to 50 ℃ together, allow it slowly cool to room temperature then to wherein adding glycol dimethyl ether; With the ice bath cooling, left standstill 12 hours then, have a large amount of white solids to separate out;
(3) repeating step (2) operating process is 3 times;
(4) obtain (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) (ee 99.25%) of high purity and optical purity at last.
Embodiment 5 (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) preparation:
(1) the borine tetrahydrofuran solution that embodiment 1 is made is bathed with cryosel and is cooled to-20 ℃~10 ℃, is homemade (+)-α-Pai Xi (CAS:7785-70-8) of 60% to wherein slowly dripping ee value under the nitrogen protection, and the maintenance temperature is less than 0 ℃; After being added dropwise to complete, under 0 ℃ of temperature, left standstill 10~24 hours, have a large amount of white solids to separate out;
(2) supernatant liquid is shifted, stay layer solid and, solid is heated to 50 ℃ together, allow it slowly cool to room temperature then to wherein adding glycol dimethyl ether; With the ice bath cooling, left standstill 12 hours then, have a large amount of white solids to separate out;
(3) repeating step (2) operating process is 3 times;
(4) obtain (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) (ee 99.43%) of high purity and optical purity at last.
Embodiment 6 (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) preparation:
(1) the borine tetrahydrofuran solution that embodiment 1 is made is bathed with cryosel and is cooled to-20 ℃~10 ℃, is homemade (+)-α-Pai Xi (CAS:7785-70-8) of 70% to wherein slowly dripping ee value under the nitrogen protection, and the maintenance temperature is less than 0 ℃; After being added dropwise to complete, under 0 ℃ of temperature, left standstill 10~24 hours, have a large amount of white solids to separate out;
(2) supernatant liquid is shifted, stay layer solid and, solid is heated to 50 ℃ together, allow it slowly cool to room temperature then to wherein adding glycol dimethyl ether; With the ice bath cooling, left standstill 12 hours then, have a large amount of white solids to separate out;
(3) repeating step (2) operating process is 3 times;
(4) obtain (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) (ee 99.30%) of high purity and optical purity at last.
Embodiment 7 (+)-B-methoxyl group two different loose camphyl borine (CAS:99438-28-5) preparation methods comprises the steps:
(1) (+) that embodiment 2 is made-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) nitrogen protection is down dry, in glove box accurately behind the weighing 286.3g; , nitrogen protection is transferred in the 5L there-necked flask, adds the 4L anhydrous methanol to there-necked flask, reacts under-20~0 ℃ of temperature;
(2) after reaction was finished, solvent evaporated with anhydrous n-hexane washing 2 times, obtained (+)-B-methoxyl group two different loose camphyl borine (CAS:99438-28-5) 306g productive rate 96.8%.
Embodiment 8 (-) B-methoxyl group two different loose camphyl borine (CAS:85134-98-1) preparation methods comprise the steps:
(1) (-) that embodiment 3 is made-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) nitrogen protection is down dry, in glove box accurately behind the weighing 286.3g; , nitrogen protection is transferred in the 5L there-necked flask, adds the 4L anhydrous methanol to there-necked flask, reacts under-20~0 ℃ of temperature;
(2) after reaction was finished, solvent evaporated with anhydrous n-hexane washing 2 times, obtained (-)-B-methoxyl group two different loose camphyl borine (CAS:85134-98-1) 306g productive rate 96.8%.
The mensuration of embodiment 9 (+)-diisopinocampheylchloroborane thiazolinyl borine optical purity:
(1) gets (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) solid 2g that obtains among the embodiment 3,, drip 2~3ml water under the stirring at room to wherein adding the 5ml glycol dimethyl ether; To the sodium hydroxide solution that wherein adds 5ml 2M, reacted 10 minutes then;
(2) to the hydrogen peroxide that wherein adds 5ml 30%, 50-60 ℃ was reacted 1 hour.
(3) cooling back separatory, organic phase is collected; Water ethyl acetate extraction 2 times; Merge organic phase, saturated common salt water washing 2 times, anhydrous magnesium sulfate drying;
(4) remove by filter anhydrous magnesium sulfate, collect solution;
(5) remove solvent ethylene glycol dme and ethyl acetate with Rotary Evaporators, the oily liquids that obtains Skellysolve A recrystallization.Obtain white solid;
(6) measure fusing point, 53-55 ℃;
(7) measure optically-active, be+35.4 °, ee value 99.15% (+35.7 ° (maximum c=10 benzene)).
The mensuration of embodiment 10 (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) optical purity:
(1) gets (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) solid 2g that obtains among the embodiment 5,, drip 2~3ml water under the stirring at room to wherein adding the 5ml glycol dimethyl ether; To the sodium hydroxide solution that wherein adds 5ml 2M, reacted 10 minutes then;
(2) to the hydrogen peroxide that wherein adds 5ml 30%, 50-60 ℃ was reacted 1 hour.
(3) cooling back separatory, organic phase is collected; Water ethyl acetate extraction 2 times; Merge organic phase, saturated common salt water washing 2 times, anhydrous magnesium sulfate drying;
(4) remove by filter anhydrous magnesium sulfate, collect solution;
(5) remove solvent ethylene glycol dme and ethyl acetate with Rotary Evaporators, the oily liquids that obtains Skellysolve A recrystallization.Obtain white solid;
(6) measure fusing point, 53-55 ℃;
(7) measure optically-active, be-35.5 °, ee value 99.43% (35.7 ° (maximum c=10 benzene)).

Claims (6)

1. the preparation method of diisopinocampheylchloroborane thiazolinyl borine comprises following step:
(1) the borine tetrahydrofuran solution is cooled to-20 ℃~10 ℃ with the cryosel bath, to wherein slowly dripping (+)-α-Pai Xi (CAS:7785-70-8) or (-)-α-Pai Xi (CAS:7785-26-4), keeps temperature under the nitrogen protection less than 0 ℃; After being added dropwise to complete, under 0 ℃ of temperature, left standstill 10~24 hours, have a large amount of white solids to separate out;
(2) supernatant liquid is shifted, stay layer solid and, solid is heated to 40 ℃~80 ℃ together, allow it slowly cool to room temperature then to wherein adding glycol dimethyl ether; With the ice bath cooling, left standstill 10~24 hours then, have a large amount of white solids to separate out;
(3) repeating step (2) operating process is 2~3 times;
(4) in step (1), drip (+)-α-Pai Xi (CAS:7785-70-8) and make (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7); In step (1), drip (-)-α-Pai Xi (CAS:7785-26-4) and make (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5).
2. according to the preparation method of the described diisopinocampheylchloroborane thiazolinyl of claim 1 borine, it is characterized in that: described borine Preparation of lithium triethylborohydride method, it comprises the steps:
(1) under the condition of nitrogen protection, will put into there-necked flask with the tetrahydrofuran (THF) that the sodium silk was handled, to wherein adding sodium borohydride, be cooled to-25 ℃~-15 ℃; Then to wherein slowly dripping boron trifluoride ether solution; In the dropping process, keep temperature-25 ℃~-15 ℃;
(2) be added dropwise to complete after, allow temperature slowly rise to room temperature, leave standstill and separated out a large amount of solids in 10~24 hours, obtaining upper strata water white transparency liquid is exactly the borine tetrahydrofuran solution;
Wherein, the used composition of raw materials ratio of above-mentioned processing step is: tetrahydrofuran (THF) 3~4L, sodium borohydride 0.08~0.12kg, boron trichloride diethyl ether solution 0.4~0.5L.
3. the preparation method of (+)-B-methoxyl group two different loose camphyl borines (CAS:99438-28-5) is characterized in that: (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) and the anhydrous methanol reaction of claim 1 preparation are made (+)-B-methoxyl group two different loose camphyl borines (CAS:99438-28-5).
4. according to the preparation method of claim 3 described (+)-B-methoxyl group two different loose camphyl borines (CAS:99438-28-5), comprise the steps:
(1) (+)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21947-87-5) nitrogen protection of claim 1 preparation is dry down, after the accurate weighing, nitrogen protection is transferred in the there-necked flask in glove box, add anhydrous methanol to there-necked flask, under-20~0 ℃ of temperature, react;
(2) after reaction was finished, solvent evaporated with anhydrous n-hexane washing 2 times, obtained (+)-B-methoxyl group two different loose camphyl borines (CAS:99438-28-5).
5. the preparation method of (-)-B-methoxyl group two different loose camphyl borines (CAS:85134-98-1) is characterized in that: (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) and the anhydrous methanol reaction of claim 1 preparation are made (-)-B-methoxyl group two different loose camphyl borines (CAS:85134-98-1).
6. according to the preparation method of claim 5 described (-)-B-methoxyl group two different loose camphyl borines (CAS:85134-98-1), comprise the steps:
(1) (-)-diisopinocampheylchloroborane thiazolinyl borine (CAS:21932-54-7) nitrogen protection of claim 1 preparation is dry down, after the accurate weighing, nitrogen protection is transferred in the there-necked flask in glove box, add anhydrous methanol to there-necked flask, under-20~0 ℃ of temperature, react;
(2) after reaction was finished, solvent evaporated with anhydrous n-hexane washing 2 times, obtained (-)-B-methoxyl group two different loose camphyl borines (CAS:85134-98-1).
CN201010145774.5A 2010-04-13 2010-04-13 Method for preparing diisopinocampheylborane and methoxydiisopinocampheylborane Active CN102219798B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201010145774.5A CN102219798B (en) 2010-04-13 2010-04-13 Method for preparing diisopinocampheylborane and methoxydiisopinocampheylborane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201010145774.5A CN102219798B (en) 2010-04-13 2010-04-13 Method for preparing diisopinocampheylborane and methoxydiisopinocampheylborane

Publications (2)

Publication Number Publication Date
CN102219798A true CN102219798A (en) 2011-10-19
CN102219798B CN102219798B (en) 2015-04-08

Family

ID=44776526

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201010145774.5A Active CN102219798B (en) 2010-04-13 2010-04-13 Method for preparing diisopinocampheylborane and methoxydiisopinocampheylborane

Country Status (1)

Country Link
CN (1) CN102219798B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103030658A (en) * 2012-06-29 2013-04-10 山东威智医药工业有限公司 Industrial production method of diisopinocampheyl chloroborane
CN103880785A (en) * 2013-12-31 2014-06-25 无锡市华斌生物科技有限公司 Industrial pollution-free production method of borane ester complex
WO2016008387A1 (en) * 2014-07-18 2016-01-21 上海格物致知医药科技有限公司 Method for preparing high purity borane gas and use of the borane gas
CN108329338A (en) * 2016-06-30 2018-07-27 苏州大学 A method of preparing borate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1778805A (en) * 2004-11-22 2006-05-31 浙江大学 Production of methy borate alkane tetrahydrofuran complex solution
CN101016299A (en) * 2006-02-09 2007-08-15 北京典范科技有限责任公司 Process for preparing purine derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1778805A (en) * 2004-11-22 2006-05-31 浙江大学 Production of methy borate alkane tetrahydrofuran complex solution
CN101016299A (en) * 2006-02-09 2007-08-15 北京典范科技有限责任公司 Process for preparing purine derivatives

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C. F. LANE, ET AL.: "(−)-ISOPINOCAMPHEOL", 《ORGANIC SYNTHESES, COLL.》, vol. 6, 31 December 1988 (1988-12-31), pages 719 *
GEORGE W. KABALKA, ET AL.: "A SIMPLE AND CONVENIENT METHOD FOR THE OXIDATION OF ORGANOBORANES USING SODIUM PERBORATE: (+)- ISOPINOCAMPHEOL", 《ORGANIC SYNTHESES, COLL.》, vol. 9, 31 December 1998 (1998-12-31), pages 116 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103030658A (en) * 2012-06-29 2013-04-10 山东威智医药工业有限公司 Industrial production method of diisopinocampheyl chloroborane
CN103030658B (en) * 2012-06-29 2015-08-19 山东威智医药工业有限公司 The industrialized preparing process of diisopinocampheylchloroborane
CN103880785A (en) * 2013-12-31 2014-06-25 无锡市华斌生物科技有限公司 Industrial pollution-free production method of borane ester complex
WO2016008387A1 (en) * 2014-07-18 2016-01-21 上海格物致知医药科技有限公司 Method for preparing high purity borane gas and use of the borane gas
CN108329338A (en) * 2016-06-30 2018-07-27 苏州大学 A method of preparing borate
CN108329338B (en) * 2016-06-30 2019-09-10 苏州大学 A method of preparing borate

Also Published As

Publication number Publication date
CN102219798B (en) 2015-04-08

Similar Documents

Publication Publication Date Title
Partridge et al. Enantioselective Synthesis and Cross‐Coupling of Tertiary Propargylic Boronic Esters Using Lithiation–Borylation of Propargylic Carbamates
CN102219798B (en) Method for preparing diisopinocampheylborane and methoxydiisopinocampheylborane
Kumar et al. Enantioselective cross dehydrogenative coupling reaction catalyzed by Rose Bengal incorporated-Cu (I)-dimeric chiral complexes
CN105153209A (en) Synthetic method for tetra(pentafluorophenyl)borate
CN104370976B (en) Oxygen-containing substituents Er Mao Tie oxazoline phosphine ligands, it is prepared and the application in Asymmetrical annular-addition reaction
CN103897027A (en) Key intermediate crystal form, preparation method and application of key intermediate crystal form in bortezomib synthesis
CN101885740A (en) New preparation method of herbicide glyphosate
CN103214534A (en) Preparation method of 3'-desoxyadenossine
Stepanenko et al. Enantioselective reduction of prochiral ketones using spiroborate esters as catalysts
CN105085267A (en) Synthetic method for salvianolic acid A
CN102964233A (en) Synthetic method of 3,5-2-fluoro-(trifluoromethyl)benzophenone
CN103044192A (en) Method for synthesizing luliconazole intermediate-(S)-2,4-dichloro-1-(1,2-dichloroethyl) benzene
CN102659520B (en) Synthetic method of 2,3,5,6-tetrafluorobenzyl alcohol
CN103626649B (en) A kind of method preparing Pelretin acid
CN111377850B (en) Chiral N-substituted-3,3-difluoro-4-hydroxypiperidine derivative and preparation method thereof
CN102617366B (en) Preparation method of (S)-5-chloro-alpha-(cyclopropyl acetylene)-2-amino-alpha-(trifluoromethyl) benzyl alcohol
CN101698633A (en) Method for preparing trifluoromethyl benzyl alcohol by Grignard reaction
CN105294479A (en) Preparation method of 3R-amino substituted butyrylamide derivative
CN102190569B (en) Method for preparing Prasugrel intermediate alpha-cyclopropylcarbonyl-2-fluorobenzyl bromide
Duan et al. Crystal Structure Studies towards the Synthesis and Applications of N-heterocyclic Carbene–Metal Complexes Derived from [2.2] Paracyclophane
CN101210026A (en) Method for preparing sodium tetraphenylborate
CN104447506A (en) Preparation method of 2-acetyl-9-alkyl carbazole
Guillon et al. Crystal Structure of 2, 8-Bis (trifluoromethyl)-4-vinylquinoline
CN104926847A (en) Boron amine compound synthesis technology and product application
CN103012170A (en) Preparation method of 4-methoxyphenethylamine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: Feng Hu

Inventor after: Yao Junna

Inventor before: Feng Hu

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: FENG HU TO: FENG HU YAO JUNNA

C14 Grant of patent or utility model
GR01 Patent grant